Contents
Overview
OLAPARIB is a Schedule H drug.Olaparib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Olaparib tablets and capsules are used to treat advanced ovarian cancer in women with a certain abnormal inherited gene who have received at least 3 prior types of chemotherapy.
Olaparib tablets are also used to help maintain your body’s response to prior chemotherapy for ovarian cancer, fallopian tube cancer or peritoneal cancer when cancer has come back.
Olaparib tablets are also used to treat HER2-negative breast cancer that has spread to other parts of the body before or after prior chemotherapy or hormonal treatment.
Usage
OLAPARIB is generally used to treat: Ovarian Cancer, Breast CancerFrequently Asked Questions
Q: Is it safe on my liver?A: Check with your Doctor first
Q: Is it safe on my kidney?
A: Not Safe
Q: Can I take it with alcohol?
A: Not Safe
Q: Is it safe for children?
A: Ask your doctor
Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must
How Do I Take It?
Route of Administration: OralPrecautions
Do not crush, chew, dissolve, or break an olaparib capsule or tablet. Swallow the pill whole. Olaparib capsules must not be used as a substitute for olaparib tablets. These two pill forms are not taken in the same dosage amounts.Common Side-Effects
OLAPARIB : Nausea, Vomit, Loss Of Appetite, Constipation, Bad Taste In Mouth, Dizziness, Arms Joint Pain, Fatigue (tiredness), Pale Skin, Rapid Breathing, Rapid Heart Rate (pulse), Fever, Chills, Throat SorenessSerious Side-Effects
OLAPARIB : Anemia, Shortness Of Breath, Cough, Wheezing, Ankles Swelling, Feet Swelling, Hands Swelling, Blood Or Red Colored Urine, Bloody Or Red Colored StoolsRare Side-Effects
OLAPARIB : Skin Rash, Body Itching, Face Swelling, Difficulty BreathingTechnical Classification
OLAPARIB is categorized as: PARP INHIBITORS / ANTINEOPLASTICSStorage Conditions
Room Temperature (Between 15 To 25 C)Available Alternatives
What are the other drugs with similar Ingredients?
OLAPARIB | OLAPARIB |